Comments

Tevogen Bio Holdings Stock Price, Quotes and Forecasts

Q: What sector and industry does Tevogen Bio Holdings (TVGN) operate in?

Tevogen Bio Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

TVGNNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Tevogen Bio Holdings (TVGN) Forecast

News Earnings Tevogen Bio Holdings (TVGN) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Tevogen Bio Holdings Stock Price, Quotes and Forecasts | NASDAQ:TVGN | Benzinga

Explore Tevogen Bio Holdings stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for TVGN.

Open	$1.27
Close	-
Volume / Avg.	86.29K / 938.39K
Day Range	$1.24 - $1.31
52 Wk Range	0.26 - 3.09
Market Cap	$235.35M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	3.66%
Days to Cover	2.89

Recent News

Why Leggett & Platt Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Tevogen Bio Holdings Stock Is Soaring After Hours: What's Going On?

Tevogen Bio Holdings shares are ripping higher in Monday's after-hours session after the company reaffirmed its oncology pipeline revenue forecast.

Adam Eckert

Tevogen Bio's T-Cell Therapy Approach Stands Out, Analyst Sees Strong Potential

D Boral Capital initiates Buy on Tevogen Bio citing its scalable T-cell therapies and upcoming clinical readouts, with a $10 price target.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.27
Close	-
Volume / Avg.	86.29K / 938.39K
Day Range	$1.24 - $1.31
52 Wk Range	0.26 - 3.09
Market Cap	$235.35M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	52
Short Interest	3.66%
Days to Cover	2.89

About Tevogen Bio Holdings Inc.

Sector

Health Care

Industry

Biotechnology

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Tevogen Bio Holdings (TVGN) stock?

You can purchase shares of Tevogen Bio Holdings (NASDAQ:TVGN) through any online brokerage.

View our list of the best stock brokerages

Who are Tevogen Bio Holdings (TVGN) competitors?

Other companies in Tevogen Bio Holdings’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Inozyme Pharma (NASDAQ:INZY), Monopar Therapeutics (NASDAQ:MNPR), Silence Therapeutics (NASDAQ:SLN) and Genfit (NASDAQ:GNFT).

What is the forecast, or price target, for Tevogen Bio Holdings (TVGN) stock?

Tevogen Bio Holdings has a consensus price target of $10.00.

What is the current price for Tevogen Bio Holdings (TVGN)?

The stock price for Tevogen Bio Holdings (NASDAQ: TVGN) is $1.2798 last updated June 17, 2025 at 1:03 PM EDT.

Does Tevogen Bio Holdings (TVGN) pay a dividend?

There are no upcoming dividends for Tevogen Bio Holdings.

When is Tevogen Bio Holdings (NASDAQ:TVGN) reporting earnings?

Tevogen Bio Holdings’s Q2 earnings are confirmed for Wednesday, August 13, 2025.

Is Tevogen Bio Holdings (TVGN) going to split?

There is no upcoming split for Tevogen Bio Holdings.

What sector and industry does Tevogen Bio Holdings (TVGN) operate in?

Tevogen Bio Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.